Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JoeChris38
    Junior Member
    • Mar 2013
    • 7

    #1

    Targeted sequencing of ~40Mb genome

    I am looking to do targeted sequencing on approximately ~40Mb of mouse genome (~2% of the genome) from low input DNA (~100pg). Equivalent to sequencing the equivalent of 2 exomes worth of DNA from 20 cells.

    My current approach has been to design large primer pools to PCR amplify ~40Mb from ~100pg DNA input thus capturing and amplifying the required 40Mb in one step. I have had varying levels of success with this approach but I am now looking for alternative methods.

    Has anyone been doing a similar sort of protocol? Or maybe have any ideas on how I could reproducibly capture and amplify 2% of a mouse genome from low DNA input?

    Thanks!
  • qingchang
    Junior Member
    • Jul 2010
    • 3

    #2
    Is it possible to do WGA with MDA and then use your primer pool towards library construction?

    100pg should be enough to do WGA.

    Comment

    • JoeChris38
      Junior Member
      • Mar 2013
      • 7

      #3
      I have thought about this option but I think my lack of reproducibility from the primer pool is as a result of the primer pool itself and not due to the low template input. Though I will be attempting what you suggest in the next couple of weeks.

      I am also going to attempt WGA (probably with Qiagen's REPLI-g kit i.e. MDA) but would like to try an alternative method of capturing the 2% of the genome I require (other than my current primer pool).

      Any ideas on alternative methods of reproducible 2% genome capture would be much appreciated.

      Comment

      • qingchang
        Junior Member
        • Jul 2010
        • 3

        #4
        Would REPLI-g Single Cell Kit followed by ION Exome custom design work for you?

        Comment

        • SNPsaurus
          Registered Vendor
          • May 2013
          • 525

          #5
          You might try using the PCR primers to generate biotinylated amplicons, and then do a pulldown of indexed Nextera XT fragments from each sample, either one at a time or pooled. The pulldown efficiency will be low, but you could still multiplex plenty of samples in a lane.

          That way, you do the PCRs with lots of input so better quality. You perform Nextera XT fragmentation on the samples and amplify them and pool to get sufficient quantities for hybridization. Might need to do 2 rounds of hybridization.

          We did something similar with biotinylated BACs (http://www.genetics.org/content/189/3/767.short), but didn't have to deal with the low input. That might be too low for good Nextera XT libraries, but we use 1-5 ng on regular Nextera and get sequencing libraries out. Not sure if it will work but thought I'd toss out an idea!
          Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

          Comment

          • maoshigua
            Junior Member
            • Aug 2013
            • 3

            #6
            targeted sequencing

            Hi all,
            Now it is not a problem to get the targeted sequencing data. But there are some general problems in dealing with them. For example, when you try to perform SNPs calling, which dataset you will use as the reference sequences (if there is no good genome sequence available)? the targeted sequences which you used to design the probes (CDS data) or the de novo assembled contigs? or other options? Does anyone have any suggestions in this case?

            Many thanks in advance.

            Mao

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Working...